Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as an adjuvant in brachial plexus block and EC50 for propofol TCI at loss of consciousness
ChiCTR-IPR-16009752Phase 4Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Nantong University
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine, ropivacaine and propofol in perioperative pain and None (3 arms), sponsored by The Second Affiliated Hospital of Nantong University. Primary endpoints: effect-site propofol concentration at loss of consciousness and bispectral index (BIS). Planned start Dec 2016; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacainepropofol
03
Conditions
perioperative pain
Beyond the preview
Go deeper on ChiCTR-IPR-16009752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16009752.